Downloads: 364
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
j.bbrc.2015.12.025.pdf | 1.05 MB | Adobe PDF | View/Open |
Title: | The modeling of Alzheimer's disease by the overexpression of mutant Presenilin 1 in human embryonic stem cells |
Authors: | Honda, Makoto Minami, Itsunari Tooi, Norie Morone, Nobuhiro Nishioka, Hisae Uemura, Kengo Kinoshita, Ayae Heuser, John E. Nakatsuji, Norio Aiba, Kazuhiro |
Keywords: | Alzheimer's disease Cellular disease model Human embryonic stem cell Presenilin 1 Synaptic dysfunction |
Issue Date: | 15-Jan-2016 |
Publisher: | Academic Press Inc. |
Journal title: | Biochemical and Biophysical Research Communications |
Volume: | 469 |
Start page: | 587 |
End page: | 592 |
Abstract: | Cellular disease models are useful tools for Alzheimer's disease (AD) research. Pluripotent stem cells, including human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), are promising materials for creating cellular models of such diseases. In the present study, we established cellular models of AD in hESCs that overexpressed the mutant Presenilin 1 (PS1) gene with the use of a site-specific gene integration system. The overexpression of PS1 did not affect the undifferentiated status or the neural differentiation ability of the hESCs. We found increases in the ratios of amyloid-β 42 (Aβ42)/Aβ40 and Aβ43/Aβ40. Furthermore, synaptic dysfunction was observed in a cellular model of AD that overexpressed mutant PS1. These results suggest that the AD phenotypes, in particular, the electrophysiological abnormality of the synapses in our AD models might be useful for AD research and drug discovery. |
Rights: | © 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
URI: | http://hdl.handle.net/2433/218506 |
DOI(Published Version): | 10.1016/j.bbrc.2015.12.025 |
PubMed ID: | 26687948 |
Appears in Collections: | Journal Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.